PDRN mainly works through the following two mechanisms:
Activation of adenosine A2A receptors: PDRN can activate adenosine A2A receptors, thereby regulating inflammatory responses and apoptosis. This process exerts a powerful anti-inflammatory effect by reducing the release of pro-inflammatory cytokines (such as IL-6, IL-1β, TNF-α, etc.) and promoting the expression of anti-inflammatory cytokines (such as IL-10).
In addition, the activation of A2A receptors can also promote the secretion of EGF (epidermal growth factor), FGF (fibroblast growth factor) and VEGF (vascular endothelial growth factor), thereby accelerating tissue repair and wound healing.
Remedial pathway: Damaged or hypoxic tissues cannot synthesize DNA from scratch. PDRN recycles the bases and nucleosides produced by the decomposition of DNA and RNA through the remedial pathway, and converts them into nucleotides and re-incorporates them into DNA, thereby accelerating the repair of damaged cells.
